נגישות
menu      
חיפוש מתקדם
תחביר
חפש...
הספר "אוצר וולקני"
אודות
תנאי שימוש
ניהול
קהילה:
אסיף מאגר המחקר החקלאי
פותח על ידי קלירמאש פתרונות בע"מ -
The presence of non-isotype-specific antibodies in polyclonal anti-IgE reagents: Demonstration of their binding to specifically selected Epstein-Barr virus-transformed cell lines
Year:
1988
Source of publication :
Cellular Immunology
Authors :
סלע, שלמה
;
.
Volume :
113
Co-Authors:
Steinitz, M., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Tamir, S., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Sela, S.B., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Rosenmann, E., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Facilitators :
From page:
10
To page:
19
(
Total pages:
10
)
Abstract:
Polyclonal anti-human IgE reagents were earlier shown to contain variable amounts of non-isotype-specific antibodies depending on the strategy used for their preparation. The presence of these antibodies in two commercial anti-IgE reagents was demonstrated in this work by (a) their binding to human Ig-surface-positive lymphoblastoid cells specifically selected by one of the polyclonal anti-human IgE reagents and (b) their binding to the non-IgE immunoglobulins secreted by those lymphoblastoid cells. Peripheral blood B lymphocytes from two normal and two atopic patients were immortalized with Epstein-Barr virus (EBV) and then selected for cells that rosette with anti-IgE-coated erythrocytes. Selection was repeated four times and cells were then cloned. The cloned cells formed rosettes and their supernatants agglutinated erythrocytes coated with rabbit anti-IgE. The immunoglobulins of these clones were positive in an ELISA for IgE, using two different polyclonal anti-human IgE reagents. They were shown, however, to be 19 S IgMs. This discrepancy was due apparently to substantial contamination of anti-non-IgE-isotype-specific antibodies in the polyclonal anti-IgE reagents used both in the selection of cells and in the ELISA. The human monoclonal B-cell lines which were applied here as targets amplified the non-IgE-isotype specific antibody contamination present in the polyclonal anti-human IgE reagents. Because of the normally very low frequency of IgE-positive cells, the use of polyclonal anti-IgE reagents to detect these cells has to be carefully evaluated. © 1988.
Note:
Related Files :
Animal
Cell Line, Transformed
epstein barr virus
goats
Immunoglobulin Isotypes
Rabbits
עוד תגיות
תוכן קשור
More details
DOI :
10.1016/0008-8749(88)90002-0
Article number:
Affiliations:
Database:
סקופוס
Publication Type:
מאמר
;
.
Language:
אנגלית
Editors' remarks:
ID:
32844
Last updated date:
02/03/2022 17:27
Creation date:
17/04/2018 01:12
You may also be interested in
Scientific Publication
The presence of non-isotype-specific antibodies in polyclonal anti-IgE reagents: Demonstration of their binding to specifically selected Epstein-Barr virus-transformed cell lines
113
Steinitz, M., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Tamir, S., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Sela, S.B., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
Rosenmann, E., Department of Pathology, Hebrew University, Hadassah Medical School, Post Office Box 1172 Jerusalem, Israel
The presence of non-isotype-specific antibodies in polyclonal anti-IgE reagents: Demonstration of their binding to specifically selected Epstein-Barr virus-transformed cell lines
Polyclonal anti-human IgE reagents were earlier shown to contain variable amounts of non-isotype-specific antibodies depending on the strategy used for their preparation. The presence of these antibodies in two commercial anti-IgE reagents was demonstrated in this work by (a) their binding to human Ig-surface-positive lymphoblastoid cells specifically selected by one of the polyclonal anti-human IgE reagents and (b) their binding to the non-IgE immunoglobulins secreted by those lymphoblastoid cells. Peripheral blood B lymphocytes from two normal and two atopic patients were immortalized with Epstein-Barr virus (EBV) and then selected for cells that rosette with anti-IgE-coated erythrocytes. Selection was repeated four times and cells were then cloned. The cloned cells formed rosettes and their supernatants agglutinated erythrocytes coated with rabbit anti-IgE. The immunoglobulins of these clones were positive in an ELISA for IgE, using two different polyclonal anti-human IgE reagents. They were shown, however, to be 19 S IgMs. This discrepancy was due apparently to substantial contamination of anti-non-IgE-isotype-specific antibodies in the polyclonal anti-IgE reagents used both in the selection of cells and in the ELISA. The human monoclonal B-cell lines which were applied here as targets amplified the non-IgE-isotype specific antibody contamination present in the polyclonal anti-human IgE reagents. Because of the normally very low frequency of IgE-positive cells, the use of polyclonal anti-IgE reagents to detect these cells has to be carefully evaluated. © 1988.
Scientific Publication
You may also be interested in